课题基金 / 基金详情

SYNTHESIS OF MARINE DERIVED MACROCYCLIC SALICYLATES

SYNTHESIS OF MARINE DERIVED MACROCYCLIC SALICYLATES
海洋衍生大环水杨酸盐的合成
批准号:
7721420
负责人:
JEF KAREL DE BRABANDER
金额:
$0.03万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-01 至 2009-01-31

项目摘要

项目成果

JEF KAREL DE BRABANDER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Research in our laboratory focuses on the synthesis of complex molecular architectures; in particular naturally occurring substances with novel structural features and interesting biological function. Unpredictable and unique chemical reactivity patterns oftentimes encountered during the assembly of a particular natural product target continues to challenge synthetic chemists. Taking advantage of the research environment at UT Southwestern, we are increasingly integrating molecular pharmacology and biochemical aspects into our research program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural elucidation and development of agonists for the human orexin receptors
  • 批准号:
    9751989
  • 项目类别:
  • 资助金额:
    $55.63万
  • 财政年份:
    2017
  • 负责人:
    JEF KAREL DE BRABANDER
  • 依托单位:
Structural elucidation and development of agonists for the human orexin receptors
  • 批准号:
    9513162
  • 项目类别:
  • 资助金额:
    $56.7万
  • 财政年份:
    2017
  • 负责人:
    JEF KAREL DE BRABANDER
  • 依托单位:
Structural elucidation and development of agonists for the human orexin receptors
  • 批准号:
    10241919
  • 项目类别:
  • 资助金额:
    $55.63万
  • 财政年份:
    2017
  • 负责人:
    JEF KAREL DE BRABANDER
  • 依托单位:
Chemistry and Cancer Scientific Program
  • 批准号:
    10260734
  • 项目类别:
  • 资助金额:
    $3.22万
  • 财政年份:
    2010
  • 负责人:
    JEF KAREL DE BRABANDER
  • 依托单位:
海外基金